Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
As cancer among younger people spikes, more patients are raising young children. The emotional and financial challenges can be intense.
-
CDC Public Health Associate Bri McNulty, who talked to NPR about being summarily fired last week, got an email that she had her job back. In the meantime, McNulty got a job offer at Penn State.
-
One rural Iowa hospital is trying to remotely connect its patients with more specialists from around the state. But cuts to federal funds might disrupt efforts like that.
-
Bri McNulty, 23, won her dream job as a CDC fellow working on cancer prevention in Iowa, the state with the second highest incidence of cancer. But she was fired, like so many federal workers.
-
New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after cancer. -
Last week, the NIH abruptly changed its funding rules for scientific research, prompting chaos and uncertainty for scientific researchers everywhere, including in cancer research clinical trials.
-
Chemicals, pesticides and intense concentrations are all things that may be in the liquid versions of marijuana that are vaporized and inhaled. -
This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.
-
Cancer is increasingly survivable, but younger people are getting the disease at higher rates, then facing myriad challenges with life afterward.
-
The FDA is expected to propose a new rule Wednesday that would mean cigarettes have lower nicotine limits to make them less addictive.
